Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2025

ELCC 2025 Colloquium

ESMO-ELCC-2025-1000x1000

The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.

26/03/2025

ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer

Watch session

  • Welcome and introduction
    Pilar Garrido Lopez
  • Clinical case of localised NSCLC relapsing with oncogene-addicted metastases and analysis of real-world biomarker testing strategies
    Mariana Brandao
  • How to optimise the science and workflows for biomarker testing in localised NSCLC: Tissue and plasma
    Frederique Penault-Llorca
  • State-of-the-art biomarker-driven management of patients with oncogene-addicted localised NSCLC
    Pilar Garrido Lopez
  • Ongoing clinical research activity for patients with localised oncogene-addicted NSCLC
    Fabrice Barlesi
  • Q&A
  • Concluding remarks
    Mariana Brandao

All resources from ELCC 2025 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.